Patrick Fivey

Company: AstraZeneca

Job title: Director Precision Medicine Policy

Seminars:

How the EU IVDR Impacts Both the Development & Access to the Pharmaceutical Industry’s Precision Medicines 8:30 am

The EU IVDR introduces new impactful requirements for pharma’ for the use of IVDs both before and after the approval of precision medicines. Shortages of both CE marked and in-house IVDs , for use with precision medicines, may impact access to key treatments. The approval process for IVDs used within clinical trials of precision medicines…Read more

day: Conference Day Two - AM